| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1235934
[patent_doc_number] => 06689758
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-10
[patent_title] => 'Gene therapy method'
[patent_app_type] => B1
[patent_app_number] => 09/701749
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 21828
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/689/06689758.pdf
[firstpage_image] =>[orig_patent_app_number] => 09701749
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/701749 | Gene therapy method | Jan 28, 2001 | Issued |
Array
(
[id] => 7093761
[patent_doc_number] => 20010034331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'EDG family gene, human H218'
[patent_app_type] => new
[patent_app_number] => 09/771063
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12011
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20010034331.pdf
[firstpage_image] =>[orig_patent_app_number] => 09771063
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/771063 | EDG family gene, human H218 | Jan 25, 2001 | Abandoned |
Array
(
[id] => 1588463
[patent_doc_number] => 06482617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-19
[patent_title] => 'Viable contaminant particle free adenoviruses, their preparation and use'
[patent_app_type] => B2
[patent_app_number] => 09/769352
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 24
[patent_no_of_words] => 13983
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482617.pdf
[firstpage_image] =>[orig_patent_app_number] => 09769352
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/769352 | Viable contaminant particle free adenoviruses, their preparation and use | Jan 25, 2001 | Issued |
Array
(
[id] => 7064636
[patent_doc_number] => 20010043922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-22
[patent_title] => 'Complementary adenoviral vector systems and cell lines'
[patent_app_type] => new
[patent_app_number] => 09/766405
[patent_app_country] => US
[patent_app_date] => 2001-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9782
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20010043922.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766405
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766405 | Complementary adenoviral vector systems and cell lines | Jan 18, 2001 | Abandoned |
Array
(
[id] => 6889567
[patent_doc_number] => 20010025022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-27
[patent_title] => 'HNOVILR'
[patent_app_type] => new
[patent_app_number] => 09/758664
[patent_app_country] => US
[patent_app_date] => 2001-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9452
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20010025022.pdf
[firstpage_image] =>[orig_patent_app_number] => 09758664
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/758664 | HNOVILR | Jan 10, 2001 | Abandoned |
Array
(
[id] => 6500233
[patent_doc_number] => 20020025522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Compositions comprising genome segments and methods of using the same'
[patent_app_type] => new
[patent_app_number] => 09/753892
[patent_app_country] => US
[patent_app_date] => 2001-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11410
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025522.pdf
[firstpage_image] =>[orig_patent_app_number] => 09753892
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/753892 | Compositions comprising genome segments and methods of using the same | Jan 2, 2001 | Issued |
Array
(
[id] => 1589011
[patent_doc_number] => RE037933
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis'
[patent_app_type] => E1
[patent_app_number] => 09/740876
[patent_app_country] => US
[patent_app_date] => 2000-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 39
[patent_no_of_words] => 12711
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/037/RE037933.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740876
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740876 | Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis | Dec 20, 2000 | Issued |
Array
(
[id] => 6908310
[patent_doc_number] => 20010011077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-02
[patent_title] => 'Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides'
[patent_app_type] => new
[patent_app_number] => 09/742858
[patent_app_country] => US
[patent_app_date] => 2000-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9993
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20010011077.pdf
[firstpage_image] =>[orig_patent_app_number] => 09742858
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/742858 | Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides | Dec 20, 2000 | Abandoned |
Array
(
[id] => 6750944
[patent_doc_number] => 20030045465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Histidine copolymer and methods for using same'
[patent_app_type] => new
[patent_app_number] => 10/018103
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16221
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045465.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018103 | Histidine copolymer and methods for using same | Dec 19, 2000 | Issued |
Array
(
[id] => 698606
[patent_doc_number] => 07067309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Defective adenoviruses and corresponding complementation lines'
[patent_app_type] => utility
[patent_app_number] => 09/739007
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15343
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067309.pdf
[firstpage_image] =>[orig_patent_app_number] => 09739007
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/739007 | Defective adenoviruses and corresponding complementation lines | Dec 18, 2000 | Issued |
Array
(
[id] => 6882672
[patent_doc_number] => 20010049144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-06
[patent_title] => 'Methods for high level expression of genes in primates'
[patent_app_type] => new
[patent_app_number] => 09/733368
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21043
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20010049144.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733368
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733368 | Methods for high level expression of genes in primates | Dec 7, 2000 | Abandoned |
Array
(
[id] => 768838
[patent_doc_number] => 07005277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-28
[patent_title] => 'Defective adenoviruses and corresponding complementation lines'
[patent_app_type] => utility
[patent_app_number] => 09/725720
[patent_app_country] => US
[patent_app_date] => 2000-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15305
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/005/07005277.pdf
[firstpage_image] =>[orig_patent_app_number] => 09725720
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/725720 | Defective adenoviruses and corresponding complementation lines | Nov 29, 2000 | Issued |
| 09/714790 | Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization | Nov 16, 2000 | Abandoned |
| 09/710035 | Somatic gene therapy to suppress secondary cataract formation following eye surgery | Nov 9, 2000 | Abandoned |
| 09/693970 | Gene Therapy | Oct 22, 2000 | Abandoned |
Array
(
[id] => 779143
[patent_doc_number] => 06995010
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-07
[patent_title] => 'Gene transfer method'
[patent_app_type] => utility
[patent_app_number] => 10/111708
[patent_app_country] => US
[patent_app_date] => 2000-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7755
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/995/06995010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10111708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/111708 | Gene transfer method | Oct 22, 2000 | Issued |
| 09/666238 | Methods and compositions for the treatment of defects in lipoprotein metabolism | Sep 20, 2000 | Abandoned |
| 09/666615 | Apparatus for microinjection of sample into amphibian oocytes | Sep 19, 2000 | Abandoned |
Array
(
[id] => 1595155
[patent_doc_number] => 06492164
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Circular DNA expression cassettes for gene transfer'
[patent_app_type] => B1
[patent_app_number] => 09/655728
[patent_app_country] => US
[patent_app_date] => 2000-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14757
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492164.pdf
[firstpage_image] =>[orig_patent_app_number] => 09655728
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/655728 | Circular DNA expression cassettes for gene transfer | Sep 4, 2000 | Issued |
| 09/581082 | Method for obtaining cleistogamous mutants of crucifers | Aug 20, 2000 | Abandoned |
